ZELUVALIMAB
UNII DX474PAV6P

Substance Identification & Data

This profile provides standardized clinical and technical data for Zeluvalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DX474PAV6P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2315361-37-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DX474PAV6P

CAS Registry Number

2315361-37-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZELUVALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C161597

National Cancer Institute reference terminology for clinical and research data.

INN ID

11417

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-06

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zeluvalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELUVALIMAB

Common Names & Synonyms

AMG 404 [WHO-DD]

ANTI-PD-1 MONOCLONAL ANTIBODY AMG 404

IMMUNOGLOBULIN G1 (295-CYSTEINE,300-GLYCINE,305-CYSTEINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN MONOCLONAL 20C1.009 MAB .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 20C1.009 MAB .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1; HPD-1; ANTIGEN=CD279)), HUMAN MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-450)(VH (HOMO SAPIENS IGHV3-23*03 (93%)-(IGHD)-IGHJ1*01 (91%)) (8.8.13) (1-120)-IGHG1*03 (CH1(R97>K(217)), CH2(R62>C(295), N67>G(300), V72>C(305))) (121-450)) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (97%)-IGKJ4*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELLS, NON-GLYCOSYLATED

RECOMBINANT HUMAN IGG1 KAPPA ANTI PD1 MONOCLONAL ANTIBODY AMG 404

ZELUVALIMAB (IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY)

ZELUVALIMAB [INN]

ZELUVALIMAB [USAN]